Advertisement
Singapore markets close in 1 hour 51 minutes
  • Straits Times Index

    3,299.96
    +9.26 (+0.28%)
     
  • Nikkei

    38,179.46
    -49.65 (-0.13%)
     
  • Hang Seng

    19,080.57
    +116.89 (+0.62%)
     
  • FTSE 100

    8,433.76
    0.00 (0.00%)
     
  • Bitcoin USD

    61,643.02
    +669.15 (+1.10%)
     
  • CMC Crypto 200

    1,266.66
    +6.46 (+0.51%)
     
  • S&P 500

    5,222.68
    +94.89 (+1.85%)
     
  • Dow

    39,512.84
    +837.14 (+2.16%)
     
  • Nasdaq

    16,340.87
    +184.57 (+1.14%)
     
  • Gold

    2,355.70
    -19.30 (-0.81%)
     
  • Crude Oil

    78.24
    -0.02 (-0.03%)
     
  • 10-Yr Bond

    4.5040
    +0.0040 (+0.09%)
     
  • FTSE Bursa Malaysia

    1,602.21
    +1.54 (+0.10%)
     
  • Jakarta Composite Index

    7,104.02
    +15.23 (+0.21%)
     
  • PSE Index

    6,604.25
    +92.32 (+1.42%)
     

AstraZeneca wins two approval recommendations from EU agency

FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the NYSE in New York

(Reuters) - The European medicines watchdog has recommended approving AstraZeneca Plc's <AZN.L> treatments for a form of heart failure and a lung disorder, the British drugmaker said on Monday.

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended approving Forxiga for treating a form of heart failure and Trixeo Aerosphere for a form of lung disorder known as "smoker's lung".

(Reporting by Aakash Jagadeesh Babu in Bengaluru; Editing by Aditya Soni)